Strongyloidiasis complicating immunosuppression for pemphigus vulgaris

British Journal of Dermatology

Volumn 169, Issue 6, 2013, Pages 1363-1364

  Walker, S L ^a   Mann, T A N ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AZATHIOPRINE; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3 ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IVERMECTIN; LANSOPRAZOLE; PREDNISOLONE; DERMATOLOGICAL AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANTIBODY TITER; ASYMPTOMATIC DISEASE; BANGLADESH; BETA THALASSEMIA; CASE REPORT; CLINICAL EXAMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; EROSION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MICROCYTOSIS; ORAL BLISTER; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; REPEAT PROCEDURE; SAUDI ARABIA; SEROLOGY; SKIN BIOPSY; STEROID THERAPY; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TRAVEL; ANIMAL; CHEMICALLY INDUCED; OPPORTUNISTIC INFECTION; PEMPHIGUS;

ADULT; ANIMALS; AZATHIOPRINE; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; OPPORTUNISTIC INFECTIONS; PEMPHIGUS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 84888984927     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12512     Document Type: Letter

References (7)

1. Kulthanan K, Chularojanamontri L, Tuchinda P, et al,. Clinical features and course of pemphigus in Thai patients. Asian Pac J Allergy Immunol 2011; 29: 161-8.
2. Whitty CJ, Carroll B, Armstrong M, et al,. Utility of history, examination and laboratory tests in screening those returning to Europe from the tropics for parasitic infection. Trop Med Int Health 2000; 5: 818-23.
3. Checkley AM, Chiodini PL, Dockrell DH, et al,. Eosinophilia in returning travellers and migrants from the tropics: U.K. recommendations for investigation and initial management. J Infect 2010; 60: 1-20.
4. Gill GV, Welch E, Bailey JW, et al,. Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. QJM 2004; 97: 789-95.
5. Mejia R, Nutman TB,. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis 2012; 25: 458-63.
6. Nigam R, Levitt J,. Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease? J Drugs Dermatol 2012; 11: 622-5.
7. Incani RN, Hernández M, González ME,. Hyperinfection by Strongyloides stercoralis probably associated with rituximab in a patient with mantle cell lymphoma and hyper eosinophilia. Rev Inst Med Trop Sao Paulo 2010; 52: 221-4.